Extrawell Pharmaceutical Holdings Limited
Extrawell Pharmaceutical Holdings Limited (HKSE: 858) is trading at HK$0.08, about ₹1 at today's HKD/INR rate, as of 30 Sep 2026, 2:19 AM ET. Indian residents can buy Extrawell Pharmaceutical from India on Paasa under the RBI's Liberalised Remittance Scheme.
Quote
Today's low
HK$0.08
Today's high
HK$0.08
52 week low
HK$0.05
52 week high
HK$0.12
858 opened at HK$0.08, closed previously at HK$0.08, and has traded between HK$0.05 and HK$0.12 over the past 52 weeks.
About
Extrawell Pharmaceutical Holdings Limited, an investment holding entity, specializes in the pharmaceutical sector. Its operations encompass the creation, production, promotion, distribution, and sale of medicinal goods throughout the People's Republic of China. The company strategically organizes its activities across three main divisions: Manufacturing, Trading, and Gene Development. Among its significant offerings is a transfer factor oral solution, which functions as a dual immune system modulator, effective against viral infections and conditions stemming from compromised cellular immunity. Another prominent product, Wisk, addresses a range of ailments including moderate to severe radiation burns, typical thermal burns, sun-induced skin inflammation, various types of infectious and oral ulcers, as well as aiding in the recovery from physical trauma and surgical procedures. Additionally, Extrawell provides ZhouBang, a thromboxane synthetase inhibitor designed to hinder platelet aggregation and promote vasodilation. Beyond its proprietary products, the firm also handles the marketing and distribution of imported pharmaceuticals, such as Millibar, prescribed for hypertension. It is also actively engaged in the research and development of an oral insulin formulation. Extrawell's portfolio extends to the commercialization and advancement of genomic technologies, including the management of gene invention rights. Further business interests include offering agency services and engaging in real estate investments. The company's main office is situated in Quarry Bay, Hong Kong.
Key statistics
Avg. volume
2.02M
Market cap
HK$223.30M
P/E Ratio
-0.20
Price-to-sales ratio
4.34
Enterprise value
HK$256.97M
Free cash flow yield
0.00%
Debt-to-equity ratio
0.45
Return on equity
-261.19%
ROIC
-1.76%
Beta
0.00
Dividend yield
0.00%
Last dividend
HK$0.00
Financial overview
Revenue
HK$51.48M
Earnings per share
-HK$0.40
Free cash flow
HK$0.00
Net profit margin
-1903.05%
Gross margin
44.19%
EBITDA
-HK$1.77M
Revenue growth
-7.12%
Similar securities
This is not an investment recommendation
How to buy Extrawell Pharmaceutical from India
Indian residents can buy Extrawell Pharmaceutical shares through Paasa in four steps. Funds leave India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name with Interactive Brokers.
Open a Paasa account
Complete digital KYC with your PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.
Add funds under LRS
Transfer INR from your Indian bank account. Your bank reports the remittance under the RBI's Liberalised Remittance Scheme and converts it to US dollars and then to HKD.
Search for Extrawell Pharmaceutical and place an order
Find Extrawell Pharmaceutical by name or by its ticker, 858, and choose an order type. Many Hong Kong listings trade in board lots, so the smallest order is one lot rather than one share. Extrawell Pharmaceutical trades 7:00 am – 1:30 pm IST; orders can only execute during that window.
Track holdings and download tax reports
Follow your Extrawell Pharmaceutical position in HKD and INR. Extrawell Pharmaceutical pays no dividend today, so your filing is the capital-gains statement plus the Schedule FA holding line.
Read the full guide: how to invest in Extrawell Pharmaceutical from India
Trading and taxes when buying Extrawell Pharmaceutical from India
Trading and limits
- Trading hours
- 9:30 am – 4:00 pm HKT
- LRS limit
- $250,000Per financial year, under the RBI's Liberalised Remittance Scheme.
Tax for Indian residents
- TCS on remittance
- 20%Collected by your bank on LRS remittances above ₹10 lakh in a financial year. The TCS is adjustable against your income-tax liability.Adjusting TCS against your tax
- Capital gains in India
- 12.5% or slab rateGains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate.Capital gains explained
- Dividends
- NoneExtrawell Pharmaceutical does not currently pay a dividend. If it starts, dividends are taxed at your slab rate in India.Dividend tax explained
- Estate or inheritance tax
- May applyHong Kong has no estate duty.Estate tax explained
Custody. Shares are held in your own name at Interactive Brokers, segregated from Paasa's own assets.
FAQs
Can Indian residents buy Extrawell Pharmaceutical stock?
Yes. Extrawell Pharmaceutical (858) has been listed on the Hong Kong Stock Exchange since 1999, in the Drug Manufacturers - Specialty & Generic industry, and Indian residents can buy it through Paasa. You fund the account from your Indian bank under the RBI's Liberalised Remittance Scheme and the money is converted to US dollars and then to HKD. Shares are held in your own name at Interactive Brokers, segregated from Paasa's own assets.
How much does one Extrawell Pharmaceutical share cost in rupees?
One Extrawell Pharmaceutical share is HK$0.08 — about ₹1 at an HKD/INR rate of 12.24 on 29 Sep 2026. Both the Extrawell Pharmaceutical price and the rupee rate move during the day, so the rupee cost changes with them.
What are the LRS and TCS rules for buying Extrawell Pharmaceutical from India?
Remit up to $250,000 per financial year under the RBI's Liberalised Remittance Scheme (LRS). Banks collect 20% tax at source on LRS remittances above ₹10 lakh in a financial year; the TCS is adjustable against your income-tax liability. FX and the LRS declaration are handled by your bank when you fund your account.
What is the minimum I can buy of Extrawell Pharmaceutical?
Many Hong Kong listings trade in board lots, so the smallest order is one lot rather than one share.
How are gains on Extrawell Pharmaceutical shares taxed in India?
Hong Kong generally does not levy capital gains tax on non-resident individual investors for HKEX-listed stocks, so the tax is an India-side one. Gains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. The gain is computed in rupees using the HKD/INR rate on the purchase and the sale date, so the rupee move counts alongside the Extrawell Pharmaceutical price. Paasa issues a capital-gains statement for your return.
Does Extrawell Pharmaceutical pay a dividend?
No. Extrawell Pharmaceutical does not currently pay a dividend, so holding it produces no dividend income to declare in India. If it starts paying one, the Indian treatment is the usual one — dividends are taxed at your slab rate in India — and Paasa's dividend report would show the gross amount and any tax withheld.
When can I trade Extrawell Pharmaceutical from India?
The Hong Kong Stock Exchange trades 7:00 am – 1:30 pm IST in Indian time. It also halts for lunch, 9:30 am – 10:30 am IST. Orders can only execute during that window.
Is there estate or inheritance tax on Extrawell Pharmaceutical shares held from India?
Hong Kong has no estate duty.
Do I have to declare Extrawell Pharmaceutical shares in my Indian tax return?
Yes. Foreign shares held on 31 March must be reported in Schedule FA of your Indian income-tax return. Paasa gives you a Schedule FA-ready statement listing your Extrawell Pharmaceutical holding, its cost and its closing value.
How do I sell Extrawell Pharmaceutical and bring the money back to India?
You sell during market hours (7:00 am – 1:30 pm IST) and the proceeds settle in HKD in your Paasa account. From there you can hold the balance, reinvest, or repatriate. Funds can be withdrawn in any currency to any bank account in your own name. Whether the sale is short- or long-term is decided by the 24-month holding period.